Background: Primary endocrine therapy (PET) is a recognised alternative to surgery followed by endocrine therapy for a subset of older women with breast cancer. Choice of treatment is therefore preference sensitive and may require decision support. The Coping in Deliberation (CODE) framework (Witt et al., 2012), which includes both cognitive and emotional appraisals of decision making and coping, is a framework which can be adapted to guide the understanding of preference-sensitive treatment decisions. Older patients are often conceptualised as passive decision-makers, and strategies to cope with stressors in older age may be different to those used by younger people. The current study aimed to examine decision making and coping in a group ...
Objective: There is variation in practice in the treatment of older women with breast cancer. Intern...
Kate J Lifford,1 Adrian Edwards,1 Maria Burton,2 Helena Harder,3 Fiona Armitage,4 Jenna L Morgan,4 L...
BackgroundRates of surgery and adjuvant therapy for breast cancer vary widely between breast units. ...
Background: Primary endocrine therapy (PET) is a recognised alternative to surgery followed by endoc...
Objective Primary Endocrine Therapy (PET) is a good alternative to surgery for breast cancer in olde...
Objective Primary Endocrine Therapy (PET) is a good alternative to surgery for breast cancer in old...
Objective: Primary endocrine therapy (PET) is an alternative to surgery for oestrogen receptor pos...
Purpose: Primary endocrine therapy (PET) is the treatment of primary, operable breast cancer with d...
Objectives: To establish older women's (≥75 years) information preferences regarding two breast canc...
Objective Primary endocrine therapy (PET) is an alternative to surgery for oestrogen receptor posit...
Objectives: To establish older women's (≥75 years) information preferences regarding two breast canc...
Primary endocrine therapy (PET) as an alternative to surgery is widely used in the UK for the treatm...
Background: Around one-third of breast cancers diagnosed every year in the UK are in women aged ≥70 ...
BACKGROUND: Decisions about adjuvant chemotherapy in older women with early stage breast cancer (EBC...
Objective: There is variation in practice in the treatment of older women with breast cancer. Intern...
Kate J Lifford,1 Adrian Edwards,1 Maria Burton,2 Helena Harder,3 Fiona Armitage,4 Jenna L Morgan,4 L...
BackgroundRates of surgery and adjuvant therapy for breast cancer vary widely between breast units. ...
Background: Primary endocrine therapy (PET) is a recognised alternative to surgery followed by endoc...
Objective Primary Endocrine Therapy (PET) is a good alternative to surgery for breast cancer in olde...
Objective Primary Endocrine Therapy (PET) is a good alternative to surgery for breast cancer in old...
Objective: Primary endocrine therapy (PET) is an alternative to surgery for oestrogen receptor pos...
Purpose: Primary endocrine therapy (PET) is the treatment of primary, operable breast cancer with d...
Objectives: To establish older women's (≥75 years) information preferences regarding two breast canc...
Objective Primary endocrine therapy (PET) is an alternative to surgery for oestrogen receptor posit...
Objectives: To establish older women's (≥75 years) information preferences regarding two breast canc...
Primary endocrine therapy (PET) as an alternative to surgery is widely used in the UK for the treatm...
Background: Around one-third of breast cancers diagnosed every year in the UK are in women aged ≥70 ...
BACKGROUND: Decisions about adjuvant chemotherapy in older women with early stage breast cancer (EBC...
Objective: There is variation in practice in the treatment of older women with breast cancer. Intern...
Kate J Lifford,1 Adrian Edwards,1 Maria Burton,2 Helena Harder,3 Fiona Armitage,4 Jenna L Morgan,4 L...
BackgroundRates of surgery and adjuvant therapy for breast cancer vary widely between breast units. ...